Yan Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Yan Li has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Daojuan Wang
State Key Laboratory of Analytical Chemistry for Life Science & Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing 210093, China
1 shared publicationHongwei Wang
State Key Laboratory of Analytical Chemistry for Life Science & Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing 210093, China
1 shared publicationJuan Wang
Soochow University Medical College
1 shared publicationLei Wang
Department of Clinical Laboratory, Jiangsu Province Hospital on Integration of Chinese and Western Medicine, China
1 shared publicationLihui Wang
Danyang Hospital Affiliated to Nantong University, Danyang, Jiangsu 212300, China
1 shared publication- Rong Wang
State Key Laboratory of Analytical Chemistry for Life Science & Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing 210093, China
1 shared publication
Latest Publications
- Open Access
- 24 August 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 2113293
Curcumin Inhibits Hyperandrogen‐Induced IRE1α‐XBP1 Pathway Activation by Activating the PI3K/AKT Signaling in Ovarian Granulosa Cells of PCOS Model Rats
Background. Hyperandrogenism is a common characteristic of polycystic ovary syndrome (PCOS). Long‐term, continuous exposure to hyperandrogenic environments may cause excessive endoplasmic reticulum (ER) stress in ovarian granulosa cells (GCs). Curcumin is a polyphenol extracted from turmeric rhizomes which has several pharmacological effects that may benefit patients with PCOS. To explore whether curcumin can inhibit hyperandrogen‐induced ER stress in ovarian GCs of PCOS rats and to elucidate the possible underlying mechanisms. Methods. We developed PCOS model rats by exposure to hyperandrogenic conditions and divided the rats into control, PCOS, and PCOS+curcumin (200 mg/kg, for 8 weeks) groups. The levels of ER stress‐related proteins and PI3K/AKT phosphorylation were measured in the ovarian tissue of all experimental groups by real‐time quantitative PCR, western blotting, immunohistochemistry, and immunofluorescence. Subsequent in vitro analysis on primary cultured GCs was performed to confirm the influence of curcumin on ER stress inhibition by immunofluorescence and western blotting. Results. Curcumin protects GCs from hyperandrogen‐induced apoptosis in PCOS model rats by inhibiting the ER stress‐related IRE1α‐XBP1 pathway and activating the PI3K/AKT signaling pathway. Conclusions. These observations indicate that curcumin might be a safe and useful supplement for PCOS patients.
- 24 August 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 2113293
Open AccessCurcumin Inhibits Hyperandrogen‐Induced IRE1α‐XBP1 Pathway Activation by Activating the PI3K/AKT Signaling in Ovarian Granulosa Cells of PCOS Model Rats
Background. Hyperandrogenism is a common characteristic of polycystic ovary syndrome (PCOS). Long‐term, continuous exposure to hyperandrogenic environments may cause excessive endoplasmic reticulum (ER) stress in ovarian granulosa cells (GCs). Curcumin is a polyphenol extracted from turmeric rhizomes which has several pharmacological effects that may benefit patients with PCOS. To explore whether curcumin can inhibit hyperandrogen‐induced ER stress in ovarian GCs of PCOS rats and to elucidate the possible underlying mechanisms. Methods. We developed PCOS model rats by exposure to hyperandrogenic conditions and divided the rats into control, PCOS, and PCOS+curcumin (200 mg/kg, for 8 weeks) groups. The levels of ER stress‐related proteins and PI3K/AKT phosphorylation were measured in the ovarian tissue of all experimental groups by real‐time quantitative PCR, western blotting, immunohistochemistry, and immunofluorescence. Subsequent in vitro analysis on primary cultured GCs was performed to confirm the influence of curcumin on ER stress inhibition by immunofluorescence and western blotting. Results. Curcumin protects GCs from hyperandrogen‐induced apoptosis in PCOS model rats by inhibiting the ER stress‐related IRE1α‐XBP1 pathway and activating the PI3K/AKT signaling pathway. Conclusions. These observations indicate that curcumin might be a safe and useful supplement for PCOS patients.
- Open Access
- 29 April 2020
- Published by Springer Nature in Research Square
Prediction and Analysis of Hub Genes in Ovarian Cancer Based on Network Analysis
Objective The aim of the present study was to identify the interactions among transcription factors (TFs), microRNAs (miRNAs) and mRNAs in ovarian serous cystadenocarcinoma (OV) to investigate the mechanisms. Method: Gene expression data were obtained from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were screened between tumor and nontumor samples using the online tool GEO2R based on the limma package of R language. The coexpression between genes was identified using the weighted gene corepression analysis (WGCNA) package of R language to construct a coding-noncoding network. Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were conducted for the genes in the coexpression network. The expression and prognostic value of the hub genes in coexpression were further validated in The Cancer Genome Atlas (TCGA) dataset. The interactions among miRNAs, mRNAs and TFs were predicted using miRGen and mirWalk to construct the TF-miRNA-mRNA regulatory network. Result The blue module was identified as significantly associated with OV, and a coexpression network were constructed through WGCNA analysis. The expression and prognostic value of the hub genes in the blue module were validated in the TCGA dataset. A total of 164 common differentially expressed miRNAs (DEMs) were screened from 2 miRNA datasets. A TF-miRNA-mRNA regulatory network composed of 2 TFs, 6 miRNAs and 199 mRNAs was constructed. QRT-PCR was also conducted to identify the expression of the 6 key miRNAs (hsa-mir-193b, hsa-mir-296, hsa-mir-29b-2, hsa-mir-29c, hsa-mir-34a and hsa-mir-421) in ovarian serous cystadenocarcinoma. Conclusion We constructed a validated TF-miRNA-mRNA network in OV, and TFs might regulate mRNAs by regulating miRNAs to act on the progression of OV.
- 29 April 2020
- Published by Springer Nature in Research Square
Open AccessPrediction and Analysis of Hub Genes in Ovarian Cancer Based on Network Analysis
Objective The aim of the present study was to identify the interactions among transcription factors (TFs), microRNAs (miRNAs) and mRNAs in ovarian serous cystadenocarcinoma (OV) to investigate the mechanisms. Method: Gene expression data were obtained from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were screened between tumor and nontumor samples using the online tool GEO2R based on the limma package of R language. The coexpression between genes was identified using the weighted gene corepression analysis (WGCNA) package of R language to construct a coding-noncoding network. Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were conducted for the genes in the coexpression network. The expression and prognostic value of the hub genes in coexpression were further validated in The Cancer Genome Atlas (TCGA) dataset. The interactions among miRNAs, mRNAs and TFs were predicted using miRGen and mirWalk to construct the TF-miRNA-mRNA regulatory network. Result The blue module was identified as significantly associated with OV, and a coexpression network were constructed through WGCNA analysis. The expression and prognostic value of the hub genes in the blue module were validated in the TCGA dataset. A total of 164 common differentially expressed miRNAs (DEMs) were screened from 2 miRNA datasets. A TF-miRNA-mRNA regulatory network composed of 2 TFs, 6 miRNAs and 199 mRNAs was constructed. QRT-PCR was also conducted to identify the expression of the 6 key miRNAs (hsa-mir-193b, hsa-mir-296, hsa-mir-29b-2, hsa-mir-29c, hsa-mir-34a and hsa-mir-421) in ovarian serous cystadenocarcinoma. Conclusion We constructed a validated TF-miRNA-mRNA network in OV, and TFs might regulate mRNAs by regulating miRNAs to act on the progression of OV.